Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer(RAZOR) : an open-label, randomised, phase 3, non-inferiority trial
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy : initial results of Radiation Therapy Oncology Group 89-03
Pathologic response rates of gemcitabine/cisplatin versus methotrexate/vinblastine/adriamycin/cisplatin neoadjuvant chemotherapy for muscle invasive urothelial bladder cancer
Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer : neoadjuvant chemotherapy and concurrent radio-chemotherapy
Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscleinvasive bladder cancer : an updated analysis of the Massachusetts General Hospital experience
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscleinvasive bladder cancer : long-term results of the BA06 30894trial
Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect
Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy : results from the US Nationwide Inpatient Sample
